Large-scale randomized controlled trials such as SUSTAIN, SELECT, and SURPASS, as well as multiple realworld cohort studies, have consistently reported no significant increase in the risk of depression, suicidality, or psychiatric hospitalization compared with placebo or other anti-diabetic agents [110-112]
Contact your healthcare provider if diarrhea persists beyond 2-4 weeks at a stable dose, if you experience severe or bloody diarrhea, signs of dehydration (dizziness, decreased urination, extreme thirst), severe abdominal pain, or if symptoms significantly interfere with daily activities or medication adherence
Any vendor explicitly marketing retatrutide for human use, weight loss, or medical treatment is operating outside legal boundaries
Jamy Ard: Served on advisory boards for Novo Nordisk and Boehringer Ingelheim